Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 CAD | +0.61% | -2.92% | -50.45% |
05-14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.45% | 19M | |
+28.74% | 49.18B | |
+0.88% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.34% | 26.09B | |
-22.53% | 18.71B | |
+8.01% | 13.26B | |
+32.17% | 12.32B | |
-0.38% | 11.99B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences : RBC Capital Keeps Outperform/Speculative Risk Rating, US$9 TP on Aptose Biosciences